Analysis of colon-specific unknown gene possibly associated with inflammatory bowel disease

可能与炎症性肠病相关的结肠特异性未知基因分析

基本信息

  • 批准号:
    12671194
  • 负责人:
  • 金额:
    $ 2.43万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

Background arid Aims : Intestinal microorganisms play role in inflammatory bowel disease. The aim of this study was to identify epithelial gene expression down-regulated by bacterial flora, and to examine expression of human homologue and possible role in minflammatory bowel disease.Methods : Germ-free mice were orally given bacterial suspension prepared from conventional components (bacterial reconstitution), and differential gene expression in intestinal epithelial cells was identified by differential display. Expression of the identified gene was examined in dextran sulfate-sodium induced colitis or human inflammatory bowel disease, by Northern blot and quantitative RT-PCR.Results : Syncollin mRNA was identified as a strongly down-regulated gene after bacterial reconstitution. In contrast, syncollin mRNA expression was stable in colonic epithelial cells of dextran sulfate-sodium -treated mice. Human syncollin mRNA deceased in UC but not CD epithelial cells in an independent manner of macroscopic inflammation.Conclusion : Since rat syncollin is an essential molecule in exocytotic pathway, decreased syncollin expression in UC may be associated with abnormal secretion.
背景和目的:肠道微生物在炎症性肠病中发挥作用。本研究的目的是鉴定细菌菌群下调的上皮基因表达,并研究人类同源基因的表达及其在炎症性肠病中的可能作用。方法:用常规成分制备的细菌悬浮液(细菌重组)口服无菌小鼠,用差异展示法鉴定肠上皮细胞的差异基因表达。通过Northern blot和定量RT-PCR检测该基因在葡聚糖硫酸钠诱导的结肠炎或人炎症性肠病中的表达。结果:细菌重组后,Syncollin mRNA被鉴定为一个强烈下调的基因。与此相反,葡聚糖磺酸钠处理小鼠结肠上皮细胞中syncollin mRNA表达稳定。人syncollin mRNA在UC上皮细胞中以独立的方式死亡,而在CD上皮细胞中不存在。结论:大鼠共联蛋白是胞外通路的重要分子,UC中共联蛋白表达减少可能与分泌异常有关。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
福島浩平 他: "Epithelial induction of Serum amyloid A in experimental mucogal in flammation"Digesfiul Diseases and Scisuces. (in press). (2002)
Kohei Fukushima 等人:“炎症中实验粘液中血清淀粉样蛋白 A 的上皮诱导”Digesfiul 疾病和剪刀(2002 年出版)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kouhei Fukushima, Hitoshi Ogawa, Taku Kitayama, Toshiyuki Yamada, Hiroo Naito, Yuji Funayama, Seiki Matsuno, Iwao Sasaki: "Epithelial induction of Serum amyloid A in experimental mucosal inflammation"Digestive Diseases and Sciences. (in press). (2002)
Kouhei Fukushima、Hitoshi Okawa、Taku Kitayama、Toshiyuki Yamada、Hiroo Naito、Yuji Funayama、Seiki Matsuno、Iwao Sasaki:“实验性粘膜炎症中血清淀粉样蛋白 A 的上皮诱导”消化疾病与科学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIBATA Chikashi其他文献

SHIBATA Chikashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIBATA Chikashi', 18)}}的其他基金

Development of oral drug to induce defecation based on the effects that stimulation to intragastric cold receptors enhances colonic motility and induce defecations
基于刺激胃内冷感受器增强结肠蠕动并诱导排便的效果,开发口服诱导排便药物
  • 批准号:
    23591953
  • 财政年份:
    2011
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A basic study on the effect of bariatric surgeries to improve type 2 diabetes : Toward days to cure severe diabetes with surgery.
关于减肥手术改善 2 型糖尿病效果的基础研究:通过手术治愈严重糖尿病的日子。
  • 批准号:
    20591586
  • 财政年份:
    2008
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
  • 批准号:
    10751760
  • 财政年份:
    2024
  • 资助金额:
    $ 2.43万
  • 项目类别:
SBIR Phase I: Engineered Induced Thymic Epithelial Cells for Novel T Cell Immunotherapies
SBIR 第一期:用于新型 T 细胞免疫疗法的工程诱导胸腺上皮细胞
  • 批准号:
    2234041
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Standard Grant
Elucidation of switching mechanism in the Wnt pathway of human amniotic epithelial cells
阐明人羊膜上皮细胞Wnt通路的转换机制
  • 批准号:
    23K15421
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
Structural diversity of ceramide moiety responsible for apical membrane function of bladder transitional epithelial cells
负责膀胱移行上皮细胞顶膜功能的神经酰胺部分的结构多样性
  • 批准号:
    23K08792
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of fasting-induced radioprotection of small intestinal epithelial cells
禁食诱导的小肠上皮细胞辐射防护机制
  • 批准号:
    10645872
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
Epigenetic regulation of lineage specification in colon epithelial cells
结肠上皮细胞谱系规范的表观遗传调控
  • 批准号:
    10676682
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
Study of the instability among mutant epithelial cells, adjacent normal epithelial cells and stromal cells to develop strategies for screening and very early detection of cancer.
研究突变上皮细胞、邻近正常上皮细胞和基质细胞之间的不稳定性,以制定癌症筛查和极早期检测策略。
  • 批准号:
    23H03102
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
MICA: Interrogating the functional impact of novel asthma genetic variants using genomics and inducible pluripotent stem cell-derived epithelial cells
MICA:利用基因组学和诱导多能干细胞衍生的上皮细胞探讨新型哮喘遗传变异的功能影响
  • 批准号:
    MR/X000974/1
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Fellowship
Efficient, controlled delivery of synthetic anion carriers to epithelial cells for CFTR replacement therapy
高效、受控地将合成阴离子载体递送至上皮细胞,用于 CFTR 替代疗法
  • 批准号:
    2904232
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了